488.58

2.02% -10.08

After Hours: 488.65 0.07 +0.01%

Hca Healthcare Inc (HCA)

Overview News Price History Option Chain Financials Why HCA Down? Discussions Forecast Dividend History

Hca Healthcare Inc stock is traded at $488.58, with a volume of 1.02M. It is down -2.02% in the last 24 hours and down -8.33% over the past month. HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.

Previous Close:

$498.66

Open:

$496.04

24h Volume:

1.02M

Relative Volume:

0.93

Market Cap:

$109.23B

Revenue:

$75.60B

Net Income/Loss:

$7.78B

P/E Ratio:

17.21

EPS:

28.3842

Net Cash Flow:

$7.69B

1W Performance:

-3.27%

1M Performance:

-8.33%

6M Performance:

+16.26%

1Y Performance:

+45.61%

1-Day Range:

$485.27

$501.93

1-Week Range:

$485.27

$512.14

52-Week Range:

$314.43

$556.52

Hca Healthcare Inc Stock (HCA) Company Profile

Name

Hca Healthcare Inc

Sector

Healthcare (1112)

Industry

Medical Care Facilities (52)

Phone

(615) 344-9551

Address

ONE PARK PLZ, NASHVILLE, TN

Employee

320,000

Twitter

@hcahealthcare

Next Earnings Date

2026-04-24

Latest SEC Filings

HCA's Discussions on Twitter

Compare HCA vs THC, FMS, ENSG, UHS

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
HCA Hca Healthcare Inc	488.58	111.48B	75.60B	7.78B	7.69B	28.38
THC Tenet Healthcare Corp	193.56	17.10B	21.31B	2.37B	2.53B	15.49
FMS Fresenius Medical Care Ag Adr	22.84	12.68B	22.18B	1.36B	2.00B	1.9216
ENSG Ensign Group Inc	197.92	11.59B	5.06B	344.26M	370.71M	5.8446
UHS Universal Health Services Inc	180.15	11.10B	17.36B	1.51B	849.25M	23.15

Hca Healthcare Inc Stock (HCA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-15-25	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Oct-14-25	Resumed	Goldman	Buy
Jul-28-25	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-16-25	Downgrade	BofA Securities	Buy → Neutral
May-29-25	Upgrade	Wells Fargo	Underweight → Equal Weight
Apr-15-25	Downgrade	Robert W. Baird	Outperform → Neutral
Dec-17-24	Resumed	JP Morgan	Neutral
Nov-25-24	Downgrade	Wells Fargo	Equal Weight → Underweight
Nov-22-24	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-11-24	Initiated	KeyBanc Capital Markets	Overweight
Sep-03-24	Initiated	Morgan Stanley	Equal-Weight
May-30-24	Initiated	Robert W. Baird	Outperform
Mar-06-24	Initiated	Barclays	Overweight
Jan-04-24	Downgrade	Bernstein	Outperform → Mkt Perform
Dec-11-23	Downgrade	Goldman	Buy → Neutral
Apr-21-23	Initiated	Cantor Fitzgerald	Overweight
Apr-19-23	Resumed	JP Morgan	Neutral
Jul-06-22	Downgrade	BMO Capital Markets	Market Perform → Underperform
Jun-17-22	Initiated	Loop Capital	Buy
May-27-22	Upgrade	Bernstein	Mkt Perform → Outperform
Mar-29-22	Initiated	Wells Fargo	Equal Weight
Jan-10-22	Resumed	Citigroup	Buy
Dec-21-21	Downgrade	JP Morgan	Overweight → Neutral
Sep-27-21	Initiated	SVB Leerink	Outperform
Sep-24-21	Initiated	UBS	Buy
Sep-10-21	Initiated	Cowen	Outperform
Aug-12-21	Downgrade	Barclays	Overweight → Equal Weight
Jul-09-21	Initiated	Seaport Global Securities	Buy
May-13-21	Resumed	Citigroup	Neutral
Apr-26-21	Downgrade	Citigroup	Buy → Neutral
Dec-15-20	Initiated	Goldman	Buy
Dec-14-20	Upgrade	JP Morgan	Neutral → Overweight
Sep-21-20	Downgrade	JP Morgan	Overweight → Neutral
Jul-13-20	Downgrade	BMO Capital Markets	Outperform → Market Perform
Sep-06-19	Upgrade	BofA/Merrill	Underperform → Neutral
Jul-10-19	Upgrade	Goldman	Neutral → Buy
Apr-23-19	Upgrade	Raymond James	Mkt Perform → Outperform
Jan-14-19	Initiated	Stephens	Overweight
Jan-03-19	Initiated	Deutsche Bank	Buy
Nov-16-18	Initiated	UBS	Buy
Mar-23-18	Resumed	Mizuho	Buy
Jan-03-18	Initiated	Goldman	Neutral
Jan-03-18	Downgrade	Piper Jaffray	Overweight → Neutral
Dec-20-17	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Dec-12-17	Upgrade	Citigroup	Neutral → Buy
Nov-30-17	Upgrade	JP Morgan	Neutral → Overweight
Nov-06-17	Reiterated	Citigroup	Neutral
Nov-01-17	Reiterated	Mizuho	Buy
Jul-26-17	Downgrade	BofA/Merrill	Buy → Neutral
Jun-28-17	Initiated	Argus	Buy

View All

Hca Healthcare Inc Stock (HCA) Latest News

05:31 AM

Universal Health Services Is A Huge Bargain At 8x Earnings Vs HCA At 16x (NYSE:UHS) - Seeking Alpha

05:31 AM

09:39 AM

Robert W. Baird Has Lowered Expectations for HCA Healthcare (NYSE:HCA) Stock Price - MarketBeat

09:39 AM

09:29 AM

Baird Adjusts Price Target on HCA Healthcare to $442 From $450, Maintains Neutral Rating - marketscreener.com

09:29 AM

08:35 AM

Cantor Fitzgerald reiterates HCA Healthcare stock rating at Overweight - Investing.com

08:35 AM

08:18 AM

HCA Florida JFK Hospital and HCA Florida Palms West Hospital Named Among the Nation’s 2026 100 Top Hospitals® by Modern Healthcare and Premier - Florida Hospital News and Healthcare Report

08:18 AM

04:32 AM

HCA Healthcare Inc stock (US4041211033): Why hospital capacity expansions matter more now for invest - AD HOC NEWS

04:32 AM

Apr 14, 2026

HCA Healthcare 2025 Unit of Distinction Awards: A decade of nursing excellence - HCA Healthcare Today

Apr 14, 2026

HCA Florida Healthcare Welcomes Dr. Luis Flores, Expanding Women’s Health Services - Florida Hospital News and Healthcare Report

Apr 14, 2026

Patton Fund Boosts Stake in HCA Healthcare - National Today

Apr 14, 2026

Patton Fund Management Inc. Buys 16,059 Shares of HCA Healthcare, Inc. $HCA - MarketBeat

Apr 14, 2026

Is HCA Undervalued? DCF Says Worth $746 - GuruFocus

Apr 14, 2026

HCA Healthcare Inc stock (US4041211033): Why its hospital network positioning matters more now for i - AD HOC NEWS

Apr 14, 2026